glp 1 without muscle loss Do GLP-1 Drugs Cause Too Much Loss? What You Need to Know Weighing the risk of GLP-1

& Janson, S

Key points Diabetes impacts about 37 million people in the United States, approximately 11.3% of the population Type 2 diabetes accounts for up to 95% of people with diabetes GLP-1 medications are also known as glucagon-like peptide-1 (GLP-1) agonists, GLP-1 receptor agonists, incretin memetics, or GLP-1 analogs GLP-1 medications lower blood sugars by binding and activating the GLP-1 receptors to enhance insulin secretion and synthesis from the pancreas by promoting beta cells, suppressing glucagon secretion, slowing gastric emptying, and reducing food intake by decreasing appetite GLP-1 medications used in combination with exercise can synergistically work together to lower blood sugar levels GLP-1 agonists, specifically dulaglutide, semaglutide, and liraglutide, have demonstrated cardiovascular reduction benefits based on large clinical trials Virtual care and questions about GLP-1 medications If you have type 2 diabetes and want to learn more about GLP-1 medications, consider speaking with a healthcare provider

[4] Maintaining open communication with the healthcare team enables timely identification and management of potential complications, optimising both safety and treatment outcomes during Ozempic therapy

Retesting iron levels 6-8 weeks after supplementation begins shows whether dietary and supplement changes are adequate or whether prescription-strength iron or intravenous iron is necessary